 | • レポートコード：GIR201110242 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、血管内皮増殖因子Bの世界市場を調査対象にし、血管内皮増殖因子Bの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他）、用途別分析（直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Alteogen Inc、Formycon AG、CSL Ltd、Eli Lilly and Company、Regeneron Pharmaceuticals Inc ・メーカー別販売量、売上、市場シェア ・血管内皮増殖因子Bの地域別市場分析 ・血管内皮増殖因子Bの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・血管内皮増殖因子Bのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・血管内皮増殖因子Bのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・血管内皮増殖因子Bの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・血管内皮増殖因子Bの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・血管内皮増殖因子Bの種類別市場規模2015-2020：アフリベルセプト、アフリベルセプトバイオシミラー、CSL-346、その他 ・血管内皮増殖因子Bの用途別市場規模2015-2020：直腸がん、網膜静脈閉塞症、糖尿病性腎症、その他 ・血管内皮増殖因子Bの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Vascular Endothelial Growth Factor B market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Vascular Endothelial Growth Factor B market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Vascular Endothelial Growth Factor B market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Vascular Endothelial Growth Factor B market has been segmented into
Aflibercept
Aflibercept Biosimilar
CSL-346
Others
By Application, Vascular Endothelial Growth Factor B has been segmented into:
Rectal Cancer
Retinal Vein Occlusion
Diabetic Nephropathy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vascular Endothelial Growth Factor B market presented in the report. This section sheds light on the sales growth of different regional and country-level Vascular Endothelial Growth Factor B markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vascular Endothelial Growth Factor B market.
The report offers in-depth assessment of the growth and other aspects of the Vascular Endothelial Growth Factor B market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Vascular Endothelial Growth Factor B Market Share Analysis
Vascular Endothelial Growth Factor B competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vascular Endothelial Growth Factor B sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vascular Endothelial Growth Factor B sales, revenue and market share for each player covered in this report.
The major players covered in Vascular Endothelial Growth Factor B are:
Alteogen Inc
Formycon AG
CSL Ltd
Eli Lilly and Company
Regeneron Pharmaceuticals Inc
Among other players domestic and global, Vascular Endothelial Growth Factor B market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vascular Endothelial Growth Factor B product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vascular Endothelial Growth Factor B, with price, sales, revenue and global market share of Vascular Endothelial Growth Factor B in 2018 and 2019.
Chapter 3, the Vascular Endothelial Growth Factor B competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vascular Endothelial Growth Factor B breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Vascular Endothelial Growth Factor B market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Vascular Endothelial Growth Factor B sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Vascular Endothelial Growth Factor B Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vascular Endothelial Growth Factor B Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Aflibercept
1.2.3 Aflibercept Biosimilar
1.2.4 CSL-346
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Vascular Endothelial Growth Factor B Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rectal Cancer
1.3.3 Retinal Vein Occlusion
1.3.4 Diabetic Nephropathy
1.3.5 Others
1.4 Overview of Global Vascular Endothelial Growth Factor B Market
1.4.1 Global Vascular Endothelial Growth Factor B Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alteogen Inc
2.1.1 Alteogen Inc Details
2.1.2 Alteogen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alteogen Inc SWOT Analysis
2.1.4 Alteogen Inc Product and Services
2.1.5 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Formycon AG
2.2.1 Formycon AG Details
2.2.2 Formycon AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Formycon AG SWOT Analysis
2.2.4 Formycon AG Product and Services
2.2.5 Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CSL Ltd
2.3.1 CSL Ltd Details
2.3.2 CSL Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CSL Ltd SWOT Analysis
2.3.4 CSL Ltd Product and Services
2.3.5 CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly and Company SWOT Analysis
2.4.4 Eli Lilly and Company Product and Services
2.4.5 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Regeneron Pharmaceuticals Inc
2.5.1 Regeneron Pharmaceuticals Inc Details
2.5.2 Regeneron Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Regeneron Pharmaceuticals Inc SWOT Analysis
2.5.4 Regeneron Pharmaceuticals Inc Product and Services
2.5.5 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Vascular Endothelial Growth Factor B Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Vascular Endothelial Growth Factor B Manufacturer Market Share in 2019
3.3.2 Top 6 Vascular Endothelial Growth Factor B Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Vascular Endothelial Growth Factor B Sales, Revenue and Market Share by Regions
4.1.1 Global Vascular Endothelial Growth Factor B Sales and Market Share by Regions (2015-2020)
4.1.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Regions (2015-2020)
4.2 North America Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
4.3 Europe Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
4.5 South America Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Vascular Endothelial Growth Factor B Sales, Revenue and Market Share by Country
5.1.1 North America Vascular Endothelial Growth Factor B Sales and Market Share by Country (2015-2020)
5.1.2 North America Vascular Endothelial Growth Factor B Revenue and Market Share by Country (2015-2020)
5.2 United States Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
5.3 Canada Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
5.4 Mexico Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Vascular Endothelial Growth Factor B Sales, Revenue and Market Share by Country
6.1.1 Europe Vascular Endothelial Growth Factor B Sales and Market Share by Country (2015-2020)
6.1.2 Europe Vascular Endothelial Growth Factor B Revenue and Market Share by Country (2015-2020)
6.2 Germany Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
6.3 UK Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
6.4 France Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
6.5 Russia Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
6.6 Italy Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Vascular Endothelial Growth Factor B Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Vascular Endothelial Growth Factor B Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Vascular Endothelial Growth Factor B Revenue and Market Share by Regions (2015-2020)
7.2 China Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
7.3 Japan Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
7.4 Korea Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
7.5 India Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
7.7 Australia Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Vascular Endothelial Growth Factor B Sales, Revenue and Market Share by Country
8.1.1 South America Vascular Endothelial Growth Factor B Sales and Market Share by Country (2015-2020)
8.1.2 South America Vascular Endothelial Growth Factor B Revenue and Market Share by Country (2015-2020)
8.2 Brazil Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
8.3 Argentina Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Vascular Endothelial Growth Factor B Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Vascular Endothelial Growth Factor B Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Vascular Endothelial Growth Factor B Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
9.3 Turkey Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
9.4 Egypt Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
9.5 South Africa Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Vascular Endothelial Growth Factor B Sales and Market Share by Type (2015-2020)
10.2 Global Vascular Endothelial Growth Factor B Revenue and Market Share by Type (2015-2020)
10.3 Global Vascular Endothelial Growth Factor B Price by Type (2015-2020)
11 Global Vascular Endothelial Growth Factor B Market Segment by Application
11.1 Global Vascular Endothelial Growth Factor B Sales Market Share by Application (2015-2020)
11.2 Global Vascular Endothelial Growth Factor B Revenue Market Share by Application (2015-2020)
11.3 Global Vascular Endothelial Growth Factor B Price by Application (2015-2020)
12 Market Forecast
12.1 Global Vascular Endothelial Growth Factor B Sales, Revenue and Growth Rate (2021-2025)
12.2 Vascular Endothelial Growth Factor B Market Forecast by Regions (2021-2025)
12.2.1 North America Vascular Endothelial Growth Factor B Market Forecast (2021-2025)
12.2.2 Europe Vascular Endothelial Growth Factor B Market Forecast (2021-2025)
12.2.3 Asia-Pacific Vascular Endothelial Growth Factor B Market Forecast (2021-2025)
12.2.4 South America Vascular Endothelial Growth Factor B Market Forecast (2021-2025)
12.2.5 Middle East & Africa Vascular Endothelial Growth Factor B Market Forecast (2021-2025)
12.3 Vascular Endothelial Growth Factor B Market Forecast by Type (2021-2025)
12.3.1 Global Vascular Endothelial Growth Factor B Sales Forecast by Type (2021-2025)
12.3.2 Global Vascular Endothelial Growth Factor B Market Share Forecast by Type (2021-2025)
12.4 Vascular Endothelial Growth Factor B Market Forecast by Application (2021-2025)
12.4.1 Global Vascular Endothelial Growth Factor B Sales Forecast by Application (2021-2025)
12.4.2 Global Vascular Endothelial Growth Factor B Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Vascular Endothelial Growth Factor B Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vascular Endothelial Growth Factor B by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vascular Endothelial Growth Factor B Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Alteogen Inc Basic Information, Manufacturing Base and Competitors
Table 8. Alteogen Inc Vascular Endothelial Growth Factor B Major Business
Table 9. Alteogen Inc Vascular Endothelial Growth Factor B Total Revenue (USD Million) (2018-2019)
Table 10. Alteogen Inc SWOT Analysis
Table 11. Alteogen Inc Vascular Endothelial Growth Factor B Product and Services
Table 12. Alteogen Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Formycon AG Basic Information, Manufacturing Base and Competitors
Table 14. Formycon AG Vascular Endothelial Growth Factor B Major Business
Table 15. Formycon AG Vascular Endothelial Growth Factor B Total Revenue (USD Million) (2018-2019)
Table 16. Formycon AG SWOT Analysis
Table 17. Formycon AG Vascular Endothelial Growth Factor B Product and Services
Table 18. Formycon AG Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 20. CSL Ltd Vascular Endothelial Growth Factor B Major Business
Table 21. CSL Ltd Vascular Endothelial Growth Factor B Total Revenue (USD Million) (2018-2019)
Table 22. CSL Ltd SWOT Analysis
Table 23. CSL Ltd Vascular Endothelial Growth Factor B Product and Services
Table 24. CSL Ltd Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 26. Eli Lilly and Company Vascular Endothelial Growth Factor B Major Business
Table 27. Eli Lilly and Company Vascular Endothelial Growth Factor B Total Revenue (USD Million) (2018-2019)
Table 28. Eli Lilly and Company SWOT Analysis
Table 29. Eli Lilly and Company Vascular Endothelial Growth Factor B Product and Services
Table 30. Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Regeneron Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 32. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Major Business
Table 33. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Total Revenue (USD Million) (2018-2019)
Table 34. Regeneron Pharmaceuticals Inc SWOT Analysis
Table 35. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Product and Services
Table 36. Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Vascular Endothelial Growth Factor B Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Vascular Endothelial Growth Factor B Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Vascular Endothelial Growth Factor B Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Vascular Endothelial Growth Factor B Sales Market Share by Regions (2015-2020)
Table 41. Global Vascular Endothelial Growth Factor B Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Vascular Endothelial Growth Factor B Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Vascular Endothelial Growth Factor B Sales Market Share by Countries (2015-2020)
Table 44. North America Vascular Endothelial Growth Factor B Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Vascular Endothelial Growth Factor B Revenue Market Share by Countries (2015-2020)
Table 46. Europe Vascular Endothelial Growth Factor B Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Vascular Endothelial Growth Factor B Sales Market Share by Countries (2015-2020)
Table 48. Europe Vascular Endothelial Growth Factor B Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Vascular Endothelial Growth Factor B Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Vascular Endothelial Growth Factor B Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Vascular Endothelial Growth Factor B Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Vascular Endothelial Growth Factor B Sales Market Share by Countries (2015-2020)
Table 54. South America Vascular Endothelial Growth Factor B Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Vascular Endothelial Growth Factor B Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Vascular Endothelial Growth Factor B Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Vascular Endothelial Growth Factor B Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Vascular Endothelial Growth Factor B Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Vascular Endothelial Growth Factor B Revenue Market Share by Countries (2015-2020)
Table 60. Global Vascular Endothelial Growth Factor B Sales by Type (2015-2020) (K Pcs)
Table 61. Global Vascular Endothelial Growth Factor B Sales Share by Type (2015-2020)
Table 62. Global Vascular Endothelial Growth Factor B Revenue by Type (2015-2020) (USD Million)
Table 63. Global Vascular Endothelial Growth Factor B Revenue Share by Type (2015-2020)
Table 64. Global Vascular Endothelial Growth Factor B Sales by Application (2015-2020) (K Pcs)
Table 65. Global Vascular Endothelial Growth Factor B Sales Share by Application (2015-2020)
Table 66. Global Vascular Endothelial Growth Factor B Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Vascular Endothelial Growth Factor B Market Share Forecast by Regions (2021-2025)
Table 68. Global Vascular Endothelial Growth Factor B Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Vascular Endothelial Growth Factor B Market Share Forecast by Type (2021-2025)
Table 70. Global Vascular Endothelial Growth Factor B Sales Forecast by Application (2021-2025)
Table 71. Global Vascular Endothelial Growth Factor B Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Vascular Endothelial Growth Factor B Picture
Figure 2. Global Sales Market Share of Vascular Endothelial Growth Factor B by Type in 2019
Figure 3. Aflibercept Picture
Figure 4. Aflibercept Biosimilar Picture
Figure 5. CSL-346 Picture
Figure 6. Others Picture
Figure 7. Vascular Endothelial Growth Factor B Sales Market Share by Application in 2018
Figure 8. Rectal Cancer Picture
Figure 9. Retinal Vein Occlusion Picture
Figure 10. Diabetic Nephropathy Picture
Figure 11. Others Picture
Figure 12. Global Vascular Endothelial Growth Factor B Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Vascular Endothelial Growth Factor B Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Vascular Endothelial Growth Factor B Sales Market Share by Manufacturer in 2019
Figure 33. Global Vascular Endothelial Growth Factor B Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Vascular Endothelial Growth Factor B Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Vascular Endothelial Growth Factor B Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Vascular Endothelial Growth Factor B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Vascular Endothelial Growth Factor B Revenue Market Share by Regions (2015-2020)
Figure 40. Global Vascular Endothelial Growth Factor B Revenue Market Share by Regions in 2018
Figure 41. North America Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
Figure 42. Europe Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
Figure 44. South America Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020)
Figure 46. North America Vascular Endothelial Growth Factor B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Vascular Endothelial Growth Factor B Sales Market Share by Countries (2015-2020)
Figure 48. North America Vascular Endothelial Growth Factor B Sales Market Share by Countries in 2018
Figure 49. North America Vascular Endothelial Growth Factor B Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Vascular Endothelial Growth Factor B Revenue Market Share by Countries in 2018
Figure 51. United States Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Vascular Endothelial Growth Factor B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Vascular Endothelial Growth Factor B Revenue Market Share by Countries in 2019
Figure 57. Germany Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Vascular Endothelial Growth Factor B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Vascular Endothelial Growth Factor B Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Vascular Endothelial Growth Factor B Revenue Market Share by Regions 2019
Figure 65. China Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Vascular Endothelial Growth Factor B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Vascular Endothelial Growth Factor B Sales Market Share by Countries in 2019
Figure 72. South America Vascular Endothelial Growth Factor B Revenue Market Share by Countries in 2019
Figure 73. Brazil Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Vascular Endothelial Growth Factor B Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Vascular Endothelial Growth Factor B Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Vascular Endothelial Growth Factor B Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Vascular Endothelial Growth Factor B Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Vascular Endothelial Growth Factor B Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Vascular Endothelial Growth Factor B Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Vascular Endothelial Growth Factor B Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Vascular Endothelial Growth Factor B Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Vascular Endothelial Growth Factor B Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Vascular Endothelial Growth Factor B Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Vascular Endothelial Growth Factor B Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
胎盤成長因子の世界市場 2020年 Market Overview The global Placenta Growth Factor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Placenta Growth Factor…- 低酸素誘導因子1アルファ阻害剤の世界市場 2020年 Market Overview The global Hypoxia Inducible Factor 1 Alpha Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hy…
- インテグリンベータ3の世界市場 2020年 Market Overview The global Integrin Beta 3 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Integrin Beta 3 market report…
- ヒト凝固因子VIIの世界市場 2020年 Market Overview The Human Coagulation Factor VII market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 線維芽細胞成長因子2の世界市場 2020年 Market Overview The global Fibroblast Growth Factor 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fibroblast Growth …